Healthcare & Life Sciences
Simsen Diagnostics
Sweden
pre-seed
pre-seed
Stage
1
Investors
About
Simsen Diagnostics develops DNA-based molecular diagnostic methods for cancer monitoring, enabling detection and tracking of cancer through DNA signals.
Explore Simsen Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.